Outcomes of concomitant surgical ablation in patients undergoing surgical myectomy for hypertrophic obstructive cardiomyopathy: A systematic review and meta-analysis.

[1]  M. Hills,et al.  Atrial fibrillation , 2022, Nature Reviews Disease Primers.

[2]  A. Bogachev-Prokophiev,et al.  Results of concomitant cryoablation for atrial fibrillation during mitral valve surgery , 2021, Interactive cardiovascular and thoracic surgery.

[3]  Shuiyun Wang,et al.  Clinical Efficacy and Safety of Cox-Maze IV Procedure for Atrial Fibrillation in Patients With Hypertrophic Obstructive Cardiomyopathy , 2021, Frontiers in Cardiovascular Medicine.

[4]  P. Sanders,et al.  Electrophysiological and Structural Remodeling of the Atria in a Mouse Model of Troponin-I Mutation Linked Hypertrophic Cardiomyopathy: Implications for Atrial Fibrillation , 2021, International journal of molecular sciences.

[5]  G. Bazoukis,et al.  Atrial substrate characterization in patients with atrial fibrillation and hypertrophic cardiomyopathy: Evidence for an extensive fibrotic disease. , 2021, Journal of electrocardiology.

[6]  A. Fabre,et al.  Characterization of atrial histology in a patient with hypertrophic cardiomyopathy: Possible evidence of a primary atrial myopathy , 2021, HeartRhythm case reports.

[7]  E. Mayo-Wilson,et al.  The PRISMA 2020 statement: an updated guideline for reporting systematic reviews , 2020, BMJ.

[8]  R. Damiano,et al.  Concomitant Cox-Maze IV and Septal Myectomy in Patients with Hypertrophic Obstructive Cardiomyopathy. , 2021, The Annals of thoracic surgery.

[9]  J. Lee,et al.  IPDfromKM: reconstruct individual patient data from published Kaplan-Meier survival curves , 2020, BMC Medical Research Methodology.

[10]  A. Bogers,et al.  Early and late post-operative arrhythmias after surgical myectomy: 45 years of follow-up. , 2020, International journal of cardiology.

[11]  Matthew W. Martinez,et al.  2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. , 2020, Journal of the American College of Cardiology.

[12]  N. Smedira,et al.  Surgical ablation of atrial fibrillation in hypertrophic obstructive cardiomyopathy: Outcomes of a tailored surgical approach , 2020, Journal of cardiac surgery.

[13]  Jeroen J. Bax,et al.  2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). , 2020, European heart journal.

[14]  S. Ommen,et al.  Does ablation of atrial fibrillation at the time of septal myectomy improve survival of patients with obstructive hypertrophic cardiomyopathy? , 2020, The Journal of thoracic and cardiovascular surgery.

[15]  A. Bogachev-Prokophiev,et al.  Single-Centre Experience of Surgical Myectomy for Hypertrophic Obstructive Cardiomyopathy. , 2020, Heart, lung & circulation.

[16]  B. Maron,et al.  Efficacy of Combined Cox-Maze IV and Ventricular Septal Myectomy for Treatment of Atrial Fibrillation in Patients With Obstructive Hypertrophic Cardiomyopathy. , 2019, The American journal of cardiology.

[17]  M. Link,et al.  Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy , 2017, Circulation.

[18]  A. Rongione,et al.  Long‐term outcome following concomitant mitral valve surgery and Cox maze procedure for atrial fibrillation , 2017, The Journal of thoracic and cardiovascular surgery.

[19]  A. Bogachev-Prokophiev,et al.  Concomitant ablation for atrial fibrillation during septal myectomy in patients with hypertrophic obstructive cardiomyopathy , 2017, Journal of Cardiothoracic Surgery.

[20]  B. Maron,et al.  Results of surgical septal myectomy for obstructive hypertrophic cardiomyopathy: the Tufts experience. , 2017, Annals of cardiothoracic surgery.

[21]  O. Alfieri,et al.  Mid-term outcomes of concomitant surgical ablation of atrial fibrillation in patients undergoing cardiac surgery for hypertrophic cardiomyopathy† , 2017, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[22]  R. Omar,et al.  Predictors of atrial fibrillation in hypertrophic cardiomyopathy , 2016, Heart.

[23]  M. Hernán,et al.  ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions , 2016, British Medical Journal.

[24]  F. Gaita,et al.  Results of Cryoablation for Atrial Fibrillation Concomitant With Video-Assisted Minimally Invasive Mitral Valve Surgery. , 2016, Seminars in thoracic and cardiovascular surgery.

[25]  Yi Shen,et al.  Outcomes of catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: a systematic review and meta-analysis. , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[26]  B. Mahmoodi,et al.  A Systematic Review and Meta-Analysis of Long-Term Outcomes After Septal Reduction Therapy in Patients With Hypertrophic Cardiomyopathy. , 2015, JACC. Heart failure.

[27]  N. Smedira,et al.  Outcomes of nonpharmacologic treatment of atrial fibrillation in patients with hypertrophic cardiomyopathy. , 2015, Heart rhythm.

[28]  N. Geller,et al.  Surgical ablation of atrial fibrillation during mitral-valve surgery. , 2015, The New England journal of medicine.

[29]  F. Rutten,et al.  2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). , 2014, European heart journal.

[30]  B. Gersh,et al.  Atrial Fibrillation in Hypertrophic Cardiomyopathy: Prevalence, Clinical Correlations, and Mortality in a Large High‐Risk Population , 2014, Journal of the American Heart Association.

[31]  B. Maron.  Surgical Myectomy Remains the Primary Treatment Option for Severely Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy , 2007 .

[32]  Raghu Kacker,et al.  Random-effects model for meta-analysis of clinical trials: an update. , 2007, Contemporary clinical trials.

[33]  N. Smedira,et al.  Effectiveness of atrial fibrillation surgery in patients with hypertrophic cardiomyopathy. , 2004, The American journal of cardiology.

[34]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[35]  B. Maron,et al.  Impact of Atrial Fibrillation on the Clinical Course of Hypertrophic Cardiomyopathy , 2001, Circulation.

[36]  W. Roberts,et al.  Diversity of Structural Mitral Valve Alterations in Hypertrophic Cardiomyopathy , 1992, Circulation.

[37]  B. Maron,et al.  Clinical and hemodynamic results after mitral valve replacement in patients with obstructive hypertrophic cardiomyopathy. , 1989, The Annals of thoracic surgery.

[38]  S. Bolling,et al.  The Society of Thoracic Surgeons 2017 Clinical Practice Guidelines for the Surgical Treatment of Atrial Fibrillation. , 2017, The Annals of thoracic surgery.